Table 2.
Comorbidity in Lp and controls.
| Concomitant diseases | Lp, n (%) | Controls n (%) | Test | p Value |
|---|---|---|---|---|
| Cardiopathy | 9 (16,4%) | 2 (3,6%) | χ2= 4,9045 | 0,027 |
| Diabetes mellitus | 2 (3,6%) | 0 | Fisher exact test | 0,248 |
| Esophageal disease | 8 (14,5%) | 3 (5,5%) | χ2= 2,5253 | 0,112 |
| Gastritis | 2 (3,6%) | 0 | Fisher exact test | 0,248 |
| Hypertension | 12 (21,8%) | 6 (10,9%) | χ2= 2,3913 | 0,122 |
| Hypovitaminosis D | 6 (10,9%) | 0 | Fisher exact test | 0,016 |
| Lung disease | 14 (25,5%) | 0 | χ2= 13,8318 | <0,001 |
| Osteoporosis | 10 (18,2%) | 1 (1,8%) | χ2= 6,4646 | 0,011 |
| Presence of removable prosthesis | 4 (7,3%) | 6 (10,9%) | χ2= 0,4400 | 0,507 |
| Raynaud syndrome | 10 (18,2%) | 0 | χ2= 8,9100 | 0,003 |
| Thyroid disease | 12 (21,8%) | 5 (9,1%) | Mid-p-test | 0,036 |
| Renal disease | 26 (47,3%) | 0 | χ2= 31,4789 | <0,001 |
| Blood disease | 24 (43,6%) | 0 | χ2= 28,1928 | <0,001 |
| Neurological disease | 7 (12,7%) | 0 | Fisher exact test | 0,006 |